Abstract
This manuscript reviews the management of patients with spontaneous dissection of the cervical internal carotid artery (sICAD). Recommendations are not based on controlled-randomized trials, but on case-control and observational, hospital-based studies, and case reports. Vascular risk factors seem to be as prevalent in patients with sICAD as in age-matched, healthy volunteers. Stroke prevention includes the treatment of vascular risk factors and the administration of oral aspirin, which may be as effective as anticoagulation. The few available data indicate that most patients with sICAD causing severe stenosis or occlusion, or an aneurysm can be treated conservatively. Patients with sICAD were not excluded in the intravenous controlled-randomized thrombolysis trials with tissue plasminogen activator, but were excluded in the intraarterial controlled-randomized thrombolysis trials. Taking the few published case series and reports on thrombolysis in patients with sICAD into consideration, intravenous thrombolysis may be beneficial, whereas it remains unclear whether intraarterial thrombolysis is useful.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mancia G, Parati G, Castiglioni P et al (2003) Daily life blood pressure changes are steeper in hypertensive than in normotensive subjects. Hypertension 42:277–282
Baumgartner RW (2008) Stroke prevention and treatment of spontaneous carotid dissection. Acta Neurochir Suppl 103:47–50
Arnold M, Pannier B, Chabriat H, Nedeltchev K, Stapf C et al (2009) Vascular risk factors and morphometric data in cervical artery dissection: a case-control study. J Neurol Neurosurg Psychiatr 80:232–234
Pezzini A, Caso V, Zanferrari C, Del Zotto E, Paciaroni M et al (2006) Arterial Hypertension as risk factor for spontaneous cervical artery dissection: a case-control study. J Neurol Neurosurg Psychiatr 77:95–97
Arnold M, Kappeler L, Georgiadis D, Berthet K, Keserue B et al (2006) Gender differences in spontaneous cervical artery dissection. Neurology 67:1050–1052
Marti B, Rickenbach M, Keil U, Stieber J, Greiser E et al (1990) Variation in coronary risk factor levels of men and women between the German-speaking MONICA centres. Rev Epidemiol Sante Publique 38:479–486
Keller U (1990) Serum cholesterol of Swiss military personnel and assessment of nutrition in military service. Schweiz Rundsch Med Prax 79:1079–1084
Marques-Vidal P, Ruidavets JB, Amouyel P, Ducimetiere P, Arveiler D et al (2004) Change in cardiovascular risk factors in France, 1985–1997. Eur J Epidemiol 19:25–32
Baumgartner RW, Arnold M, Baumgartner I, Mosso M, Gönner F et al (2001) Carotid dissection with and without ischemic events: Local symptoms and cerebral artery findings. Neurology 57:827–832
Benninger DH, Herrmann FR, Georgiadis D, Kretschmer R, Sarikaya H et al (2009) Increased prevalence of hyperhomocysteinemia in cervical artery dissection causing stroke. A case-control study. Cerebrovasc Dis 27:241–246
Gallai V, Caso V, Paciaroni M, Cardioli G, Arning E et al (2001) Mild hyperhomocysteinemia: a possible risk factor for cervical artery dissection. Stroke 32:714–718
Konrad C, Muller GA, Langer C, Kuhlenbaumer G, Berger K et al (2004) Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol 251:1242–1248
Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P et al (2002) Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 33:664–669
Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S et al (2002) Homocysteine, MTHFR 677C-T polymorphism, and risk of ischemic stroke–results of a meta-analysis. Neurology 59:529–536
Soriente L, Coppola A, Madonna P, Cerbone AM, Di Minno G et al (1998) Homozygous C677T mutation of the 5, 10 methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in Italian patients with a history of early-onset ischemic stroke. Stroke 29:869–871
Harker LA, Ross R, Slichter SJ, Scott CR (1976) Homocysteine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58:731–741
Harker LA, Slichter J, Scott CR, Russell R (1974) Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med 291:537–543
Wall RT, Harlan JM, Harker LA, Striker GF (1980) Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 18:113–121
Woo KS, Chook P, Lolin YI, Cheung AS, Chan LT et al (1997) Hyperhomocysteinemia is a risk factor for endothelial dysfunction in humans. Circulation 96:2542–2544
Boers GH, Smals AG, Trijbels FJ, Fowler B, Bakkeren JA et al (1985) Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 313:709–715
Clarke R, Daly L, Robinson K, Naughten E, Cahalane S et al (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149–1155
Abboud H, Houdart E, Meseguer E, Amarenco P (2005) Stent assisted endovascular thrombolysis of internal carotid artery dissection. J Neurol Neurosurg Psychiatry 76:292–293
Albers GW, Clark WM, Madden KP, Hamilton SA (2002) ATLANTIS trial. Results for patients treated within 3 hours of stroke onset. Stroke 33:493–496
Brattstrom L, Wilcken DE (2000) Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 72:315–323
Christen WG, Ajani UA, Glynn RJ, Hennekens CH (2000) Blood levels of homocysteine and increased risk of cardiovascular disease: causal or casual? Arch Int Med 160:422–434
Grau AJ, Brandt T, Buggle F, Orbek E, Mytilineos J et al (1999) Association of cervical artery dissection with recent infection. Arch Neurol 56:851–856
Guillon B, Lévy C, Bousser MG (1998) Internal carotid artery dissection: an update. J Neurol Sci 153:146–158
Lindgren A, Brattstrom L, Norrving B, Hultberg B, Andersson A, Johansson BB (1995) Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 26:795–800
Nurk E, Tell GS, Nygard O, Refsum H, Ueland PM, Vollset SE (2001) Plasma total homocysteine is influenced by prandial status in humans. The Hordaland homocysteine study. J Nutr 131:1214–1216
Erkula G, Jones KB, Sponseller PD, Dietz HC, Dieritz RE (2002) Growth and maturation in Marfan syndrome. Am J Med Genet 10:1000–1015
Benninger DH, Georgiadis D, Kremer C, Studer A, Nedeltchev K, Baumgartner RW (2004) Mechanism of ischemic infarct in spontaneous carotid dissection. Stroke 35:482–485
Srinivasan J, Newell DW, Sturzenegger M, Mayberg MR, Winn HR (1996) Transcranial Doppler in the evaluation of internal carotid artery dissection. Stroke 27:1226–1230
Lyrer P, Engelter S (2004) Antithrombotic drugs for carotid artery dissection. Stroke 35:613–614
Georgiadis D, Arnold M, von Buedingen HC, Valko P, Sarikaya H, et al (2009) Aspirin versus anticoagulation in carotid artery dissection: a study of 298 patients. Neurology 2009;72:1810–5
Nedeltchev K, Bickel S, Arnold M, Sarikaya H, Georgiadis D et al (2009) Recanalization of spontaneous carotid artery dissection. Stroke 40:499–504
Kremer C, Mosso M, Georgiadis D, Stöckli E, Benninger D et al (2003) Carotid dissection with permanent and transient occlusion or severe stenosis: Long-term outcome. Neurology 60:271–275
Leys D, Moulin T, Stoijkovic T, Begey S, Chavot D, Investigators DONALD (1995) Follow-up of patients with history of cervical artery dissection. Cerebrovasc Dis 5:43–49
Touzé E, Gauvrit JY, Moulin T, Meder JF, Bracard S et al (2003) Risk of stroke and recurrent dissection after a cervical artery dissection. A multicenter study. Neurology 61:1347–1351
Benninger DH, Gandjour J, Georgiadis D, Stöckli E, Arnold M, Baumgartner RW (2007) Benign long-term outcome of conservatively treated cervical aneurysms due to carotid dissection. Neurology 69:486–487
Guillon B, Brunerau L, Biousse V, Djouhri H, Lévy C, Bousser MG (1999) Long-term follow-up of aneurysms developed during extracranial internal carotid artery dissection. Neurology 53:117–122
Touzé E, Randoux B, Méary E, Arquizan C, Meder J-F, Mas J-L (2001) Aneurysmal forms of cervical artery dissection. Associated factors and outcome. Stroke 32:418–423
Georgiadis D, Baumgartner RW (2005) Thrombolysis in cervical artery dissection. In: Baumgartner RW, Bogousslavsky J, Caso V, Paciaroni M (eds) Handbook on Cerebral Artery Dissection. Karger, Basel, pp 140–146
Clark WM, Wissman M, Albers GW, Jhamandas JH, Madden KP et al (1999) Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. JAMA 282:2019–2026
Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017–1025
The National Institute of Neurological Disorders and Stroke rt-PA Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587
Derex L, Nighoghossian N, Turjman F, Hermier M, Honnorat J et al (2000) Intravenous tPA in acute ischemic stroke related to internal carotid artery dissection. Neurology 54:2159–2161
Georgiadis D, Schwab S, Engelter S, Sztajzel R, Arnold M et al (2005) Intravenous thrombolysis in patients with acute stroke due to spontaneous carotid dissection. Neurology 64:1612–1614
Rudolf J, Neveling M, Grond M, Schmulling S, Stenzel C, Heiss W (1999) Stroke following internal carotid artery occlusion - a contra-indication for intravenous thrombolysis? Eur J Neurol 6:51–55
Del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA et al (1998) PROACT: a phase I randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 29:4–11
Furlan A, Higashida R, Wechsler L, Gent M, Rowley H et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA 282:2003–2011
Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A et al (2007) Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke. The middle cerebral artery embolism local fibrinolytic Intervention trial (MELT) Japan. Stroke 38:2633–2639
Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS et al (2005) Safety and efficacy of mechanical embolectomy in acute ischemic stroke. Results of the MERCI trial. Stroke 36:1432–1440
Arnold M, Nedeltchev K, Sturzenegger M, Schroth G, Loher TJ et al (2002) Thrombolysis in patients with acute stroke caused by cervical artery dissection: analysis of 9 patients and review of the literature. Arch Neurol 59:549–553
Sampognaro G, Turgut T, Conners J Jr, White C, Collins T, Ramee SR (1999) Intra-arterial thrombolysis in a patient presenting with an ischemic stroke due to spontaneous internal carotid artery dissection. Catheter Cardiovasc Interv 48:312–315
Zaidat OO, Fernandes Filho JA, Singh G, Suarez JI (2001) Thrombolytic therapy for acute extra-cranial artery dissection: report of two cases. Arq Neuropsiquiatr 59:936–938
Nedeltchev K, Brekenfeld C, Remonda L, Ozdoba C, Dai-Do D et al (2005) Internal carotid artery stent implantation in 25 patients with acute stroke: Preliminary results. Radiology 237:1029–1037
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer-Verlag/Wien
About this chapter
Cite this chapter
Baumgartner, R.W. (2010). Management of Spontaneous Dissection of the Cervical Carotid Artery. In: Surgical Management of Cerebrovascular Disease. Acta Neurochirurgica Supplementum, vol 107. Springer, Vienna. https://doi.org/10.1007/978-3-211-99373-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-211-99373-6_9
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-99372-9
Online ISBN: 978-3-211-99373-6
eBook Packages: MedicineMedicine (R0)